Array Technologies, Inc. (NASDAQ: ARRY) Q2 2021 earnings call dated Aug. 11, 2021 Corporate Participants: Cody Mueller -- Investor Relations Jim Fusaro -- Chief Executive Officer
Array Technologies Inc
-(ARRY)
XNAS:ARRY
Earnings: Array BioPharma reports upbeat Q3 results
Array BioPharma (NASDAQ: ARRY) reported a narrower-than-expected loss in the third quarter of 2019, sending its shares up 0.5% during pre-market trading
Earnings: Array BioPharma delivers strong Q2 results, investors cheer
Array BioPharma (ARRY) reported 44% jump in second-quarter revenue to $82.5 million, driven by higher product sales and recognition of $40 million